HEMERA 1, a phase 1 trial of carboxyhemoglobin oxygen delivery for revascularization in acute stroke

Join Italo Linfante (USA) and Rodrigo Rivera (Chile) as they discuss HEMERA 1, a phase 1 trial investigating carboxyhemoglobin oxygen delivery for revascularization in acute stroke. This innovative study aims to explore the potential benefits of using carboxyhemoglobin to enhance oxygen delivery to affected brain regions during an acute stroke, with the goal of improving revascularization and patient outcomes. Watch video.

This interview was filmed at Linnc Paris 2023 .